FIGURE

Fig. 6

ID
ZDB-FIG-221210-14
Publication
Xiong et al., 2021 - SLC1A1 mediated glutamine addiction and contributed to natural killer T-cell lymphoma progression with immunotherapeutic potential
Other Figures
All Figure Page
Back to All Figure Page
Fig. 6

Clinical outcome according to EAAT3 expression in patients with NKTCL.

(a and b) Progression-free survival (PFS, upper panel) and overall survival (OS, lower panel) according to tumor EAAT3 expression in all the patients (a), and stage I-II or III-IV patients (b) treated with asparaginase-based regimens.

(c) Tumor EAAT3 expression in stage I-II or III-IV patients.

(d) Multivariate analysis of predictors indicated on the left (EAAT3 and IPI, EAAT3 and PINK, or EAAT3 and PINK-E) for PFS and OS in NKTCL. Hazard ratio (HR), 95% confidence interval (95% CI) and P value were indicated on the right of each forest plot.

P values in (a) and (b) were calculated with log-rank test. P value in (c) was calculated with Pearson's chi-square test. P values in (d) was calculated with Cox proportional hazards models.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ EBioMedicine